An Update on Antibodies to Necleosome Components as Biomarkers of Sistemic Lupus Erythematosus and of Lupus Flares
Systemic lupus erythematosus (SLE) is an autoimmune disease with variable clinical expression. It is a potentially devastating condition affecting mostly women and leading to clinically unpredictable outcomes. Remission and flares may, in fact, alternate over time and a mild involvement limited to f...
Main Authors: | Gian Marco Ghiggeri, Matteo D’Alessandro, Domenico Bartolomeo, Maria Ludovica Degl’Innocenti, Alberto Magnasco, Francesca Lugani, Marco Prunotto, Maurizio Bruschi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/22/5799 |
Similar Items
-
Clinical significance of antinucleosome antibodies in patients with “early” systemic lupus erythematosus
by: M. A. Kotovskaya, et al.
Published: (2016-05-01) -
Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas
by: Ole Petter Rekvig
Published: (2018-03-01) -
Anti-nucleosome antibodies in systemic lupus erythematosus patients: Relation to anti-double stranded deoxyribonucleic acid and disease activity
by: Mayada Ali Abdalla, et al.
Published: (2018-01-01) -
Anti-C reactive protein antibodies in Indian patients with systemic lupus erythematosus
by: V Pradhan, et al.
Published: (2013-01-01) -
CCR6+ Th cell distribution differentiates systemic lupus erythematosus patients based on anti-dsDNA antibody status
by: Wei Zhong, et al.
Published: (2018-02-01)